References
- Kulkarni R. K., Pani K. C., Neuman C., Leonard F. Polylactic acid for surgical implants. Arch Surg 1966; 93: 839–43
- Kulkarni R. K., Moore E. G., Hegyeli A. F., Leonard F. Biodegradable poly(lactic acid) polymers. J Biomed Mater Res 1971; 5: 169–81
- Kronenthal R. L. Biodegradable polymers in medicine. Polymer science and technology, R. L Kronenthal, Z Oser, E Martin. Plenum Press, New York 1975; 119–37
- Nakamura S., Ninomiya S., Takatori Y., Morimoto S., Kusaba I., Kurokawa T. Polylactide screws in acetabular osteotomy. 28 dysplastic hips followed for 1 year. Acta Orthop Scand 1993; 64: 301–2
- Pettit D. K., Lawter J. R., Huang W. J., Pankey S. C., Nightlinger N. S., Lynch D. H., et al. Characterization of poly(glycolide‐co‐D,L‐lactide)/poly(D,L‐lactide) microspheres for controlled release of GM‐CSF. Pharm Res 1997; 14: 1422–30
- Spenlehauer G., Veillard M., Benoit J. P. Formation and characterization of cisplatin loaded poly(d,l‐lactide) microspheres for chemoembolization. J Pharm Sci 1986; 75: 750–5
- Vleggaar D., Bauer U. Facial enhancement and the European experience with poly‐L‐lactic acid. J Drugs Dermatol 2004; 3: 542–7
- Woerle B., Hanke C. W., Sattler G. Poly‐L‐lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 2004; 3: 385–9
- Bauer U. Correction of facial deformities with poly‐L‐lactic acid: 40‐month follow‐up. J Eur Acad Dermatol Venereol 2004; 18((s2))193–557
- Champe P. C., Harvey R. A. Lippincott's illustrated reviews: biochemistry. 2nd ed. Lippincott Williams & Wilkins, Philadelphia 1994
- Lodish H., Berk A., Zipursky S. L. Cellular energetics: glycolysis, aerobic oxidation, and photosynthesis. Molecular cell biology. WH Freeman and Company, New York 2000; 622–6
- Gogolewski S., Jovanovic M., Perren S. M., Dillon J. G., Hughes M. K. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3‐hydroxybutyrate) (PHB), and poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135–48
- Bos R. R., Rozema F. R., Boering G., Nijenhuis A. J., Pennings A. J., Verwey A. B., et al. Degradation of and tissue reaction to biodegradable poly(L‐lactide) for use as internal fixation of fractures: a study in rats. Biomaterials 1991; 12: 32–6
- Brady J. M., Cutright D. E., Miller R. A., Barristone G. C. Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res 1973; 7: 155–66
- Cutright D. E., Perez B., Beasley J. D 3rd., Larson W. J., Posey W. R. Degradation rates of polymers and copolymers of polylactic and polyglycolic acids. Oral Surg Oral Med Oral Pathol 1974; 37: 142–52
- Sattler G. Long‐lasting results with polylactic acid. Dermatology 2003; 9: 422–3
- Sommer B. Crystalline polylactic acid (New‐Fill): current handling guidelines. Skin 2004; 15: 1–4
- Wolters M., Lampe H. Experiences with New‐Fill for the treatment of wrinkles and contour defects in the face. P 74 ISAPS 2003. Houston TX 2003
- Onesti M. G., Renzi L. F., Paoletti F., Scuderi N. Use of polylactic acid in face lipodystrophy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART). Acta Chir Plast 2004; 46: 12–15
- Valantin M. A., Aubron‐Olivier C., Ghosn J., Laglenne E., Pauchard M., Schoen H., et al. Polylactic acid implants (New‐Fill®) to correct facial lipoatrophy in HIV‐infected patients: results of the open‐label study VEGA. AIDS 2003; 17: 2471–7
- Moyle G. J., Lysakova L., Brown S., Sibtain N., Healy J., Priest C., et al. A randomized open‐label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004; 5: 82–7
- Carr A., Emery S., Law M., Puls R., Lundgren J. D., Powderly W. G. An objective case definition of lipodystrophy in HIV‐infected adults: a case–control study. Lancet 2003; 361: 726–35
- Engelhard P., Knies M. Safety and efficacy of New‐Fill® (polylactic acid) in the treatment of HIV‐associated lipoatrophy of the face (HALF). XIV International AIDS Conference 2002. Monduzzi Editore, Barcelona 2002
- Mest D. R., Humble G. Safety and efficacy of intradermal poly‐L‐lactic acid (Sculptra) injections in patients with HIV‐associated facial lipoatrophy. Antiviral Ther 2004; 9: L36